Hainan Shuangcheng Pharmaceuticals Co., Ltd.

SZSE:002693.SZ

6.85 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024202320222021202020192018201720162015201420132012201120102009
Operating Activities:
Net Income -106.269-50.742-8.496-40.809-79.959.029-92.1481.329-388.41152.67958.93366.77267.99970.41264.2332.107
Depreciation & Amortization 53.47954.04657.53754.32957.09159.0156.13343.47229.24620.68217.3812.6087.5835.6654.9963.651
Deferred Income Tax 00-0.3850.451.1621.497-0.5191.7523.121-1.707000000
Stock Based Compensation 0-3.5876.8847.194000013.9336.333000000
Change In Working Capital -28.158-20.283-4.53314.902-12.15426.10360.4-37.234112.013-29.219-12.269-10.9045.69-10.299-12.1294.985
Accounts Receivables -3.4774.991-13.835.3939.8088.18343.715-50.33853.135-70.773-1.834-13.5514.561000
Inventory -19.76-12.446-9.888-4.77-4.26639.60831.265-89.564-6.20614.21-22.433-7.156-11.257-1.828-0.611-2.428
Accounts Payables 0-9.66219.57113.831-48.857-23.185-14.06100.91561.96229.051000000
Other Working Capital -4.921-3.167-0.3850.451.1621.49729.13552.33118.218-43.42910.164-3.74916.947-8.471-11.5177.413
Other Non Cash Items 40.12232.204-25.789-12.51424.51-27.55822.454-30.104285.7992.097-13.043-12.043-1.0530.275-1.7673.524
Operating Cash Flow -40.82611.63925.21823.554-10.50266.58546.839-22.53738.64746.23951.00156.43380.21866.05355.3344.267
Investing Activities:
Investments In Property Plant And Equipment -24.908-49.197-32.983-31.639-51.57-51.508-22.385-70.154-182.968-289.675-115.937-65.063-57.907-107.149-9.51-23.324
Acquisitions Net 09.83226.97921.6753.5674.002-00.6891.9550.1060.0265.06357.920-10
Purchases Of Investments -531.399-291.515-470.958-256.2-637.19-507.58-775.288-315.25-8-835.27-1,850-2,070.56-4410-1600
Sales Maturities Of Investments 560.568352.545391.89299.163615.287599.424915.936302.046.435728.9871,703.9792,023.964280.890161.3580
Other Investing Activites 0.7782.75400-51.57-51.5087.63812.7312.178-0.653-15.13-65.063-57.9070.00400.11
Investing Cash Flow 5.03824.42-85.07232.995-71.48462.831125.901-69.944-180.4-396.505-277.068-111.659-218.004-107.145-9.152-23.214
Financing Activities:
Debt Repayment 67.5-6038-55.3455.148-139-106-7510.63490000000
Common Stock Issued 00000000063.934000000
Common Stock Repurchased 00000000-63.9340000000
Dividends Paid -7.192-8.686-11.132-9.097-9.755-10.068-16.698-7.508-25.201-43.017-36-44.0040-75.085-0.008-16.278
Other Financing Activities 17.02829.21918.06723.8150-5.264-11.35186.56466.779-6.06600550.023093.7320
Financing Cash Flow 77.337-39.46644.934-40.62145.393-154.332-134.048104.056-11.726440.917-36-44.004550.023-75.08593.724-16.278
Other Information:
Effect Of Forex Changes On Cash 0.17-0.0030.099-0.106-0.285-0.029-2.66-3.3971.1010.749-0.2970.0150.145-0.06600
Net Change In Cash 41.719-3.41-14.82115.821-36.879-24.94636.0328.178-152.37891.399-262.365-99.214412.382-116.244139.9024.776
Cash At End Of Period 45.1063.3876.79721.6185.79742.67567.62131.58923.411175.7984.391346.755445.9733.588149.8319.929